miltefosine has been researched along with antimony sodium gluconate in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.33) | 18.2507 |
2000's | 23 (53.49) | 29.6817 |
2010's | 16 (37.21) | 24.3611 |
2020's | 3 (6.98) | 2.80 |
Authors | Studies |
---|---|
Eibl, H; Kuhlencord, A; Maniera, T; Unger, C | 1 |
Croft, SL; Escobar, P; Yardley, V | 1 |
Kumar, P; Pai, K; Pandey, HP; Sundar, S; Tripathi, K | 1 |
Carter, KC; Mullen, AB; Pereira, OC; Spickett, C; Sundar, S | 1 |
Berman, J | 1 |
Garnier, JM; Minodier, P; Retornaz, K; Robert, S | 1 |
Hepburn, NC | 1 |
Bandyopadhyay, S; Chatterjee, M; Dutta, A; Mandal, C | 1 |
Dube, A; Singh, N; Sundar, S | 1 |
Kumar, A; Sundar, S | 1 |
Bange, FC; Rihl, M; Schmidt, RE; Stoll, M; Ulbricht, K | 1 |
Agrawal, D; Agrawal, S; Chakravarty, J; Chhabra, A; Kumar, K; Singh, V; Sundar, S | 1 |
Bhattacharya, SK; Karbwang, J; Sur, D | 1 |
Assefa, Y; Boots, G; Davidson, RN; Dejenie, A; den Boer, M; Hundie, TB; Mesure, J; Ritmeijer, K | 1 |
Jayswal, BP; Mishra, OP; Prasad, R; Singh, UK | 1 |
Blanc, P; Garnier, JM; Minodier, P; Noël, G; Retornaz, K; Uters, M | 1 |
Boucher, P; Hadighi, R; Khamesipour, A; Meamar, AR; Mohebali, M; Ouellette, M; Roy, G | 1 |
Kumar, A; Mitra, G; Thakur, CP; Thakur, M; Thakur, S | 1 |
Kulshrestha, A; Kumar, D; Salotra, P; Singh, R | 1 |
Chatterjee, M; Mandal, G; Sarkar, A; Singh, N; Sundar, S | 1 |
Cos, P; da Luz, RI; Maes, L; Timmermans, JP; Toté, K; Vermeersch, M | 1 |
Collini, P; Greig, J; Lockwood, D; Premchand, N | 1 |
Cos, P; da Luz, RI; Dujardin, JC; Maes, L; Vermeersch, M | 1 |
Kumar, D; Ramam, M; Ramesh, V; Salotra, P; Verma, S | 1 |
Badaro, R; Chang, KP; Day, J; Mehta, SR; Schooley, RT; Spina, C; Zhang, XQ | 1 |
Olliaro, PL | 1 |
Abuzaid, AA; Alexander, N; Balasegaram, M; Dorlo, TP; Edwards, T; Ellis, S; Khalil, EA; Kinoti, D; Kirigi, G; Musa, AM; Njoroge, N; Omollo, R; Wasunna, M; Younis, BM | 1 |
Kumar, M; Singh, N; Singh, RK | 1 |
Chakravarty, J; Sundar, S | 1 |
Abebe, T; Hailu, A; Kassahun, A; Utaile, M | 1 |
Dieterle, R; Pillekamp, H | 1 |
Gupta, S; Kant, P; Kumar, S; Shivahare, R; Suryawanshi, SN; Tiwari, A | 1 |
Cappel, MA; Keeling, JH; Kevric, I | 1 |
Basu, N; Bera, DK; Chatterjee, M; Ganguly, S; Ghosh, TK; Guha, SK; Kundu, PK; Maji, AK; Roy, S; Saha, P | 1 |
Chatterjee, M; Das, NK; Ghosh, S; Mukherjee, S; Mukhopadhyay, D; Roy, S; Saha, B | 1 |
Bifeld, E; Clos, J; Höhn, K; Tejera Nevado, P | 1 |
Alexander, N; Ali, MH; Alves, F; Balasegaram, M; Dorlo, TP; Edwards, T; Elamin, MY; Ellis, S; Hailu, A; Juma, R; Khalil, EA; Kimutai, R; Kip, AE; Kirigi, G; Musa, A; Musa, B; Njenga, S; Olobo, J; Omollo, R; Schoone, GJ; Strub Wourgaft, N; Wasunna, M; Wells, S | 1 |
Boelaert, M; Chakravarty, J; Hasker, E; Kansal, S; Kumar, A; Malaviya, P; Ostyn, B; Sundar, S | 1 |
Machado-Alba, JE; Machado-Duque, ME; Medina-Morales, DA | 1 |
Alsford, S; Baker, N; Collett, CF; Horn, D; Hutchinson, S; Kitson, C; Santrot, MV; Steele-Stallard, HB | 1 |
Çavuş, İ; Harman, M; Kaya, T; Özbilgin, A; Yıldırım, A | 1 |
Li, SH; Liu, Y; Lu, L; Niu, YN; Yang, CY; Zhang, HW; Zhao, DY; Zhao, YL; Zhou, RM; Zhu, X | 1 |
Alcoba, G; Alvar, J; Alves, F; Dorlo, TPC; Egondi, T; Fikre, H; Ismail Omer Haroun, A; Khalil, EAG; Mbui, J; Mekonnen, T; Mersha, D; Mohammed, R; Musa Younis, B; Musa, AM; Muthoni Ouattara, G; Nakanwagi, P; Njenga, S; Nour, A; Olobo, J; Omollo, T; Ritmeijer, K; Sagaki, P; Sisay, K; Solomos, A; Taha Ahmed Elmukashfi, E; Verrest, L; Wasunna, M | 1 |
10 review(s) available for miltefosine and antimony sodium gluconate
Article | Year |
---|---|
Current treatment approaches to leishmaniasis.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Fluconazole; Humans; Leishmaniasis; Paromomycin; Pentamidine; Phosphorylcholine | 2003 |
[Visceral leishmaniasis: new drugs].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2003 |
Cutaneous leishmaniasis: current and future management.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Humans; Immunotherapy; Leishmania; Leishmaniasis, Cutaneous; Paromomycin; Phosphorylcholine | 2003 |
Childhood visceral leishmaniasis.
Topics: Administration, Oral; Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Leishmania donovani; Leishmaniasis, Visceral; Phosphorylcholine; Psychodidae | 2006 |
[Treatment of visceral leishmaniasis in children].
Topics: Amphotericin B; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2007 |
Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature.
Topics: Adult; AIDS-Related Opportunistic Infections; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Therapy, Combination; HIV Seropositivity; Humans; Leishmaniasis, Visceral; Male; Phosphorylcholine; Treatment Outcome | 2009 |
Drug combinations for visceral leishmaniasis.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Cost-Benefit Analysis; Drug Resistance; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Leishmaniasis, Visceral; Paromomycin; Phosphorylcholine | 2010 |
Leishmaniasis: current status of available drugs and new potential drug targets.
Topics: Aminoquinolines; Amphotericin B; Antigens, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Caspase Inhibitors; Cyclin-Dependent Kinases; Drug Discovery; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Leishmaniasis; Macrophages; Microbodies; Mitogen-Activated Protein Kinase Kinases; Paromomycin; Pentamidine; Phosphorylcholine; Polyamines; Protease Inhibitors; Sterols; Sulfhydryl Compounds; Topoisomerase Inhibitors | 2012 |
Leishmaniasis: an update of current pharmacotherapy.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Practice Guidelines as Topic; Species Specificity; Treatment Outcome | 2013 |
New World and Old World Leishmania Infections: A Practical Review.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Deoxycholic Acid; Drug Combinations; Humans; Incidence; Leishmania braziliensis; Leishmania donovani; Leishmania mexicana; Leishmania tropica; Leishmaniasis, Diffuse Cutaneous; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Phosphorylcholine; Polymerase Chain Reaction; Travel | 2015 |
6 trial(s) available for miltefosine and antimony sodium gluconate
Article | Year |
---|---|
A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.
Topics: Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Comorbidity; Ethiopia; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Phosphorylcholine; Prevalence; Treatment Outcome | 2006 |
Miltefosine in children with visceral leishmaniasis: a prospective, multicentric, cross-sectional study.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Cross-Sectional Studies; Drug Resistance; Humans; Leishmaniasis, Visceral; Phosphorylcholine; Prospective Studies; Treatment Outcome | 2006 |
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.
Topics: Adolescent; Adult; Amphotericin B; Antimony Sodium Gluconate; Child; Drug Therapy, Combination; Humans; Kenya; Leishmaniasis, Visceral; Middle Aged; Phosphorylcholine; Research Design; Sudan; Time Factors; Treatment Outcome; Trypanocidal Agents; Young Adult | 2011 |
[Cutaneous leishmaniasis. Diagnosis and therapy in northern Afghanistan].
Topics: Administration, Topical; Adult; Afghanistan; Antimony Sodium Gluconate; Antiprotozoal Agents; Combined Modality Therapy; Cryotherapy; Dermatologic Agents; Humans; Internationality; Leishmaniasis, Cutaneous; Male; Military Personnel; Phosphorylcholine; Treatment Outcome; Young Adult | 2014 |
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.
Topics: Adolescent; Adult; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Drug Therapy, Combination; Female; Humans; Kenya; Leishmania donovani; Leishmaniasis, Visceral; Male; Middle Aged; Parasite Load; Phosphorylcholine; Sudan; Treatment Outcome; Young Adult | 2016 |
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.
Topics: Adult; Africa, Eastern; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Paromomycin; Phosphorylcholine; Treatment Outcome | 2023 |
27 other study(ies) available for miltefosine and antimony sodium gluconate
Article | Year |
---|---|
Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice.
Topics: Administration, Oral; Animals; Antimony Sodium Gluconate; Bone Marrow; Female; Leishmania; Leishmania donovani; Leishmaniasis, Visceral; Liver; Mice; Mice, Inbred BALB C; Phosphorylcholine; Spleen | 1992 |
Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Leishmania donovani; Leishmaniasis, Visceral; Liver; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mice, SCID; Phosphorylcholine; Species Specificity | 2001 |
Immunoblot analysis of the humoral immune response to Leishmania donovani polypeptides in cases of human visceral leishmaniasis: its usefulness in prognosis.
Topics: Adult; Animals; Antibodies, Protozoan; Antibody Formation; Antigens, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Immunoblotting; Leishmania donovani; Leishmaniasis, Visceral; Peptides; Phosphorylcholine; Predictive Value of Tests; Prognosis | 2002 |
The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Buthionine Sulfoximine; Drug Resistance; Female; Glutathione; Leishmania donovani; Leishmaniasis, Visceral; Male; Mice; Mice, Inbred BALB C; Paromomycin; Phosphorylcholine | 2003 |
Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania donovani; Leishmaniasis, Visceral; Parasitic Sensitivity Tests; Phosphorylcholine; Tetrazolium Salts; Thiazoles | 2005 |
Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Line; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Mesocricetus; Mice; Parasitic Diseases, Animal; Phosphorylcholine | 2005 |
Challenges in the management of visceral leishmaniasis.
Topics: Amebicides; Amphotericin B; Antimony Sodium Gluconate; Antiparasitic Agents; Antiprotozoal Agents; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Humans; Immunoglobulin G; Leishmaniasis, Visceral; Paromomycin; Pentamidine; Phosphorylcholine | 2005 |
Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
Topics: Adult; Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Europe; Germany; HIV Infections; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liposomes; Male; Phosphorylcholine; Recurrence; Treatment Outcome | 2006 |
Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.
Topics: Administration, Oral; Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Injections, Intravenous; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Phosphorylcholine; Treatment Outcome | 2006 |
Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine | 2007 |
Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate & miltefosine.
Topics: Adolescent; Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Male; Phosphorylcholine; Thrombocytopenia | 2007 |
In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; DNA Primers; Drug Resistance; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Phosphorylcholine; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescein diacetate.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Culture Media, Serum-Free; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Humans; Leishmania donovani; Pentamidine; Phosphorylcholine; Sensitivity and Specificity; Sulfhydryl Compounds | 2009 |
In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cells, Cultured; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis; Mice; Microscopy, Electron, Transmission; Parasitic Sensitivity Tests; Phosphorylcholine; Saponins; Triterpenes | 2009 |
In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cells, Cultured; Flow Cytometry; Leishmania; Leishmaniasis; Macrophages, Peritoneal; Mice; Microscopy; Parasitic Sensitivity Tests; Phosphorylcholine; Saponins; Temperature; Triterpenes | 2009 |
Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine.
Topics: Adult; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Biopsy; Female; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Middle Aged; Phosphorylcholine; Pregnancy; Treatment Outcome | 2009 |
Flow cytometric screening for anti-leishmanials in a human macrophage cell line.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Line; Cell Survival; Coloring Agents; Drug Evaluation, Preclinical; Flow Cytometry; Formazans; Humans; Leishmania mexicana; Macrophages; Phosphorylcholine; Tetrazolium Salts; Trypan Blue | 2010 |
Susceptibility of clinical isolates of Leishmania aethiopica to miltefosine, paromomycin, amphotericin B and sodium stibogluconate using amastigote-macrophage in vitro model.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cells, Cultured; Ethiopia; Humans; Inhibitory Concentration 50; Leishmania; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Mice; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine | 2013 |
Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Survival; Cells, Cultured; Chlorocebus aethiops; Inhibitory Concentration 50; Ketones; Leishmania donovani; Leishmaniasis; Macrophages; Mice; Molecular Structure; Parasitic Sensitivity Tests; Phosphorylcholine; Retinoids; Structure-Activity Relationship; Vero Cells | 2015 |
PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Disease Transmission, Infectious; Epidemiological Monitoring; Female; Humans; India; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Phosphorylcholine; Polymerase Chain Reaction; Prevalence; Recurrence; Rural Population; Young Adult | 2015 |
A male preponderance in patients with Indian post kala-azar dermal leishmaniasis is associated with increased circulating levels of testosterone.
Topics: Adolescent; Adult; Amphotericin B; Antibodies, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Progression; Female; Humans; Immunoglobulin G; India; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Neglected Diseases; Phosphorylcholine; Sex Factors; Testosterone; Young Adult | 2016 |
A Telomeric Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cadmium; Cloning, Molecular; Copper; Drosophila Proteins; Drug Resistance; Exosomes; Gene Expression; Heat-Shock Proteins; High-Throughput Nucleotide Sequencing; Leishmania infantum; Life Cycle Stages; Multigene Family; Phosphorylcholine; Protozoan Proteins; Telomere | 2016 |
Risk Factors associated with defaulting from visceral leishmaniasis treatment: analysis under routine programme conditions in Bihar, India.
Topics: Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Health Facilities; Humans; India; Leishmaniasis, Visceral; Male; National Health Programs; Patient Satisfaction; Phosphorylcholine; Primary Health Care; Private Sector; Public Sector; Specialization; Young Adult | 2017 |
Epidemiology of Cutaneous Leishmaniasis in a Colombian Municipality.
Topics: Adolescent; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Colombia; Female; Humans; Leishmaniasis, Cutaneous; Male; Phosphorylcholine; Prevalence; Retrospective Studies; Socioeconomic Factors; Urban Population; Young Adult | 2017 |
Chemogenomic Profiling of Antileishmanial Efficacy and Resistance in the Related Kinetoplastid Parasite Trypanosoma brucei.
Topics: Adenosine Triphosphatases; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Leishmania; Paromomycin; Phosphorylcholine; R-SNARE Proteins; Trypanosoma brucei brucei | 2019 |
Comparison of
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Female; Genotyping Techniques; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Paromomycin; Phosphorylcholine; Real-Time Polymerase Chain Reaction; Turkey | 2020 |
Investigating the Aggregation of Imported Cutaneous Leishmaniasis in Henan, Central China.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; China; Communicable Diseases, Imported; DNA, Kinetoplast; Humans; Leishmaniasis, Cutaneous; Phosphorylcholine; Psychodidae | 2021 |